Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 182 institutions that hold shares in the stock, with a total of 138 Million shares, which have been reported (via 13F filing form) to have a value of $170 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tpg Gp A, LLC
Fort Worth, TX |
Nov 14, 2025 Q3 2025 |
18,716,306
shares
|
$23 Million
1.5% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$20.2 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
13,971,557
shares
|
$17.2 Million
0.0% of portfolio
|
Q3 2025
Added 36.27%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
9,020,770
shares
|
$11.1 Million
0.0% of portfolio
|
Q3 2025
Added 9.22%
|
|
|
Primecap Management CO
Pasadena, CA |
Nov 10, 2025 Q3 2025 |
7,079,308
shares
|
$8.71 Million
0.01% of portfolio
|
Q3 2025
Added 23.78%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
4,360,608
shares
|
$5.36 Million
0.03% of portfolio
|
Q1 2025
Added 0.01%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
3,868,750
shares
|
$4.76 Million
0.2% of portfolio
|
Q1 2025
Added 34.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
3,833,885
shares
|
$4.72 Million
0.0% of portfolio
|
Q3 2025
Added 1.03%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
3,677,474
shares
|
$4.52 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.77%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
3,571,157
shares
|
$4.39 Million
0.0% of portfolio
|
Q3 2025
Added 75.15%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
3,390,026
shares
|
$4.17 Million
0.0% of portfolio
|
Q3 2025
Added 125.59%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,383,644
shares
|
$4.16 Million
0.01% of portfolio
|
Q3 2025
Added 109.74%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Nov 10, 2025 Q3 2025 |
2,981,396
shares
|
$3.67 Million
0.99% of portfolio
|
Q3 2025
Added 13.15%
|
|
|
Wildcat Capital Management, LLC
|
Nov 13, 2025 Q3 2025 |
2,920,787
shares
|
$3.59 Million
2.5% of portfolio
|
Q2 2024
Added 52.06%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
2,893,812
shares
|
$3.56 Million
0.01% of portfolio
|
Q3 2025
Added 73.28%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
2,781,600
shares
|
$3.42 Million
0.01% of portfolio
|
Q3 2025
Added 57.38%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,755,378
shares
|
$3.39 Million
0.0% of portfolio
|
Q3 2025
Added 1.2%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
2,090,753
shares
|
$2.57 Million
0.0% of portfolio
|
Q3 2025
Reduced 23.6%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
1,853,554
shares
|
$2.28 Million
0.0% of portfolio
|
Q3 2025
Added 2199.01%
|
|
|
Vida Ventures Advisors, LLC
|
Nov 03, 2025 Q3 2025 |
1,798,163
shares
|
$2.21 Million
100.0% of portfolio
|
Q3 2020
New holding
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
1,582,265
shares
|
$1.95 Million
0.0% of portfolio
|
Q3 2025
Added 82.45%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2025 Q3 2025 |
1,380,118
shares
|
$1.7 Million
0.46% of portfolio
|
Q1 2025
Added 11.29%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,299,166
shares
|
$1.6 Million
0.0% of portfolio
|
Q3 2025
Added 113.34%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,279,628
shares
|
$1.57 Million
0.0% of portfolio
|
Q3 2025
Added 0.42%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
1,215,773
shares
|
$1.5 Million
0.0% of portfolio
|
Q3 2025
Added 194.64%
|
|